1French R, Cowen F, Mansour, et al. Hormonally impregnated intrauterine systems versus other forms of reversible contraceptives as effective methods of preventing pregnancy [J]. Cochrane Database Syst Rev, 2001; (2) :CD001776
2Thonneau P, Goulard H, Goyaux N, et al. Risk factors for extrauterine failure [J]. Contraception,2001 ;64(1): 33-37
3Coste J, Bouyer J, Germain E, et al. Recent declining trend in ectopic pregnancy in France: evidence of two clinicoepidemiologic entities[J]. Fertil Steril, 2000;74(5) :881-886
4Bouyer J, Rachou E, Fernandez H, et al. Risk factors for extrauterine pregnancy in women using an intrauterine device[J]. Fertil Steril, 2000;74(5) :899-908
5Gazvani MR, Baruah DN, Alfirevic Z. Mifepristone in combination with methotrexate for the medical treatment of tubal pregnancy: a randomized,controlled trail[J]. Hum Reprod, 1998; 13(7): 1987
6Perdu M, Camus E, Rozenberg P, et al. Treating ectopic pregnancy with the combination of mifepristone and methotrexate: a phase Ⅱ nonrandomized study[J]. Am J Obstet Gynecol, 1998;179(3 pt 1):640
7Mol BWJ, Hajenius PJ, Engelsbel S, et al. Is conservative surgery for tubal pregnancy preferable to salpingectomy? An economic analysis[J]. Br J Obstet Gynecol, 1997; 104(4): 834
8Anne E, Damien S. Survival analysis of fertility after ectopic pregnancy[J]. Fertil Steril, 2001 ;75(3) :560
9Seifer DB. Persistent ectopic pregnancy: an argument for heightened vigilance and patient compliance[J]. Fertil Steril, 1997;68(2) :402
10Shalev E, Romano S, Peleg D, et al. Spontaneous resolution of ectopic tubal pregnancy: natural history [J]. Fertil Steril, 1995;63:15
8Stepan H,Geipel A,Schwarz F. Circulatory solubleedoglin and its predice value for preeclampsia in second-trimester pregnancies with abnorm aluterine[J].American Journal of Obstetrics and Gynecology,2008,(02):175.
